Trial Profile
A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Clindamycin/tretinoin (Primary) ; Clindamycin; Tretinoin
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- Sponsors Stiefel Laboratories
- 29 Sep 2011 Glaxosmithkline added as a trial sponsor.
- 29 Dec 2010 Official Title amended as reported by ClinicalTrials.gov.
- 01 Dec 2010 Additional trial identifier 114681 identified as reported by ClinicalTrials.gov.